Promega

ApoLive-Glo Multiplex Assay

Varenummer: G6410
Kort informasjon 10 ml
  • Produktinformasjon
  • Relaterte produkter
  • Alternative produkter
  • Spesifikasjoner
The ApoLive-Glo Multiplex Assay measures both the number of viable cells as a marker of cytotoxicity and caspase activation as a marker of apoptosis within a single assay well to determine the mechanism of cell death. The first part of the assay measures the activity of a protease marker of cell viability. The live-cell protease activity is restricted to intact viable cells and is measured using a fluorogenic, cell-permeant, peptide substrate (glycyl-phenylalanyl-amino fluorocoumarin; GF-AFC). The substrate enters intact cells, where it is cleaved by the live-cell protease activity to generate a fluorescent signal proportional to the number of living cells. This live-cell protease becomes inactive upon loss of cell membrane integrity and leakage into the surrounding culture medium. The second part of the assay uses the Caspase-Glo Assay technology to detect caspase activation, which is a key biomarker of apoptosis. The Caspase-Glo Assay provides a luminogenic caspase-3/7 substrate, which contains the tetrapeptide sequence DEVD, in a reagent optimized for caspase activity, luciferase activity and cell lysis. Adding the Caspase-Glo 3/7 Reagent in an 'add-mix-measure' format results in cell lysis, followed by caspase cleavage of the substrate and generation of a 'glow-type' luminescent signal produced by luciferase. Luminescence is proportional to the amount of caspase activity present.|
Measure Viability and Apoptosis in the Same Sample Well: Accurately determine the mechanism of cell death in less time with less sample.Easy to Implement: The assay uses a simple sequential 'add-mix-measure' format.Normalize Caspase Data with Viability Control: The ratio of caspase activity to viable cell is useful for determining the extent of caspase activation and for normalizing cell numbers.Flexible and Easily Automated: The volumes of each assay component can be scaled to meet throughput needs, and the assay is amenable to automation in 96- and 384-well plates. Reveal cell death even if the window of caspase activity is missed.Multiplex with Other Assays: The nonlytic nature of the first step of the assay allows further multiplexing with spectrally distinct fluorescent assay chemistries.

Det finnes ingen relaterte produkter.

Det finnes ingen alternative produkter.
Ekstra spesifikasjoner
Store all components at -20°C protected from light.|U.S. Pat. Nos. 7,416,854, 7,553,632 and other patents pending. U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending. U.S. Pat. Nos. 7,148,030, 7,384,758, 7,666,987 and other patents and patents pending.The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

Kontaktperson(er) til dette produktet

Christine Rindal Ibra 944 34 009 christine.rindal.ibra@nmas.no
Claudia Emmanuel 951 51 950 claudia.emmanuel@nmas.no
Monica Laukas 404 40 960 monica.laukas@nmas.no

Kontakt oss

Ønsker du mer informasjon om våre produkter eller tjenester?
Fyll inn dine kontaktopplysninger og hva saken gjelder, så tar vi kontakt med deg.

Kontaktskjema
Bedrift
Telefon
E-post
Melding